48Indexed trials
mesh condition
Amyotrophic Lateral Sclerosis
Intelligence
Amyotrophic Lateral Sclerosis intelligence: 48 indexed trials, 12 recruiting studies, 40 sponsors across 31 countries.
12Recruiting
40Sponsors
31Countries
Leading sponsors
Massachusetts General Hospital40 recruiting
Amylyx Pharmaceuticals Inc.20 recruiting
Merit E. Cudkowicz, MD20 recruiting
Wake Forest University Health Sciences20 recruiting
Beth Israel Deaconess Medical Center20 recruiting
University of Lisbon20 recruiting
Biohaven Pharmaceuticals, Inc.10 recruiting
Biogen10 recruiting
Assistance Publique Hopitaux De Marseille11 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
Duke University10 recruiting
Clene Nanomedicine10 recruiting
Geographic activity
United States29trials
France5trials
Germany5trials
Canada4trials
Italy4trials
Poland4trials
Belgium4trials
Netherlands4trials
United Kingdom4trials
Portugal3trials
Argentina2trials
Denmark2trials
Leading interventions
AMX00352trials
Matching Placebo2trials
riluzole2trials
3T MRI imaging of the brain1trials
Amyotrophic Lateral Sclerosis1trials
BHV-02231trials
Acthar1trials
CNM-Au81trials
DNL3431trials
Elecsys (Roche) Abeta42, Ttau and Ptau1trials
Five Wishes Form1trials
Baricitinib1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.